$CEOS PsyKey Expands Product Portfolio in the $8 B
Post# of 24979
(Total Views: 93)
Posted On: 03/30/2022 1:07:33 PM
$CEOS PsyKey Expands Product Portfolio in the $8 Billion Dollar Functional Mushroom Market with the Acquisition of NutraRox
CARSON CITY, NV / ACCESSWIRE / March 7, 2022 / CECORS, INC. (OTC PINK:CEOS) ("CeCors", "PsyKey" or the "Company"
. is pleased to announce that through a non-dilutive restricted stock transaction, the company has acquired 100 percent of Nutra-Rox LLC, specializing in products featuring functional carbonated crystal delivery technology (Think "Pop Rocks" like candy). Nutra-Rox formulates and manufactures innovative consumer products utilizing this patent-pending delivery technology for nutraceuticals and bioactive ingredients. Under the terms of the acquisition agreement, Nutra-Rox shareholders will be subject to a 2-year regulatory hold.
https://finance.yahoo.com/news/psykey-expands...00303.html
CARSON CITY, NV / ACCESSWIRE / March 7, 2022 / CECORS, INC. (OTC PINK:CEOS) ("CeCors", "PsyKey" or the "Company"
. is pleased to announce that through a non-dilutive restricted stock transaction, the company has acquired 100 percent of Nutra-Rox LLC, specializing in products featuring functional carbonated crystal delivery technology (Think "Pop Rocks" like candy). Nutra-Rox formulates and manufactures innovative consumer products utilizing this patent-pending delivery technology for nutraceuticals and bioactive ingredients. Under the terms of the acquisition agreement, Nutra-Rox shareholders will be subject to a 2-year regulatory hold. https://finance.yahoo.com/news/psykey-expands...00303.html
(0)
(0)Scroll down for more posts ▼